安捷伦(A)国际营收表现分析 - 雅虎财经
Agilent (A) International Revenue Performance Explored - Yahoo Finance
生物技术与制药领域的最新动态
Agilent (A) International Revenue Performance Explored - Yahoo Finance
Thermo Fisher Scientific launches CorEvitas Clinical Registry for rare autoimmune disorder - scientistlive.com
AMPK modulates a DEAH box RNA-helicase to attenuate TOR signaling and establish developmental quiescence in Caenorhabditis elegans
Glia-to-glia serotonin signaling directs MMP-dependent infiltration for experience-dependent synapse pruning
Expression of Concern: Lipoprotein Receptor LRP1 Regulates Leptin Signaling and Energy Homeostasis in the Adult Central Nervous System
Divergent and stabilizing selection shape the phenotypic space of Arabidopsis thaliana
A dynamic spatiotemporal normalization model captures perceptual and neural effects of spatial and temporal context
Holiday notice
Biopharma Sentiment Index | Q4 2025
"Heavy AI" is taking over biopharma | Signal Pulse Report
Introducing Endpoints Signal — intelligence for fresh biopharma insights
Belite continues ascent as Stargardt drug hits mark in late-stage trial
Agilent Announces 21 Cfr Part 11 Compliance Software For Xcelligence RTCA eSight - TradingView
Agilent Technologies, Inc. $A Shares Sold by Groupama Asset Managment - MarketBeat
A drugmaker charts a path through pharma’s ethical minefields
YuviTal wins Roche-backed breast cancer innovation challenge - JNS.org
Mackenzie Financial Corp Cuts Position in Agilent Technologies, Inc. $A - MarketBeat
Protego plans pivotal trial for AL amyloidosis prospect with $130M series B
Gene writing startup Tessera strikes $150M partnership with Regeneron
Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqel